{"node": "NEWLY DIAGNOSED HIV-POSITIVE Patient", "content": "Initial steps for newly diagnosed HIV-positive patients", "children": [{"node": "A", "content": "Pretest and posttest counseling", "children": [{"node": "A.1", "content": "Test limitations"}, {"node": "A.2", "content": "Treatment availability"}, {"node": "A.3", "content": "Risk reduction"}, {"node": "A.4", "content": "Available resources for support"}, {"node": "A.5", "content": "Partner disclosure"}]}, {"node": "B", "content": "Testing", "children": [{"node": "B.1", "content": "ELISA to screen for chronic infection"}, {"node": "B.2", "content": "If acute infection suspected, order ELISA and HIV viral load"}]}, {"node": "C", "content": "Detailed history", "children": [{"node": "C.1", "content": "Source of infection"}, {"node": "C.2", "content": "Risks for other STDs"}, {"node": "C.3", "content": "Substance abuse"}, {"node": "C.4", "content": "Prior Ols (tuberculosis, shingles, thrush)"}, {"node": "C.5", "content": "Prior vaccines"}, {"node": "C.6", "content": "Current medications"}, {"node": "C.7", "content": "Comorbidities, especially cardiovascular disease or risks"}, {"node": "C.8", "content": "Women: last Pap smear"}]}, {"node": "D", "content": "Detailed review of systems", "children": [{"node": "D.1", "content": "Energy, appetite, weight loss"}, {"node": "D.2", "content": "Fever, chills, night sweats"}, {"node": "D.3", "content": "Headache, visual changes, focal paresthesia, focal weakness, confusion"}, {"node": "D.4", "content": "Skin rashes"}, {"node": "D.5", "content": "Cough, shortness of breath, sputum production"}, {"node": "D.6", "content": "Abdominal pain, nausea, vomiting, dysphagia, odynophagia, diarrhea, hematochezia"}, {"node": "D.7", "content": "Dysuria, genital discharge, genital itching, genital ulcer or rash"}]}, {"node": "E", "content": "Complete physical examination", "children": [{"node": "E.1", "content": "Body mass index"}, {"node": "E.2", "content": "Funduscopy for retinal lesions"}, {"node": "E.3", "content": "Oral evaluation for opportunistic infections"}, {"node": "E.4", "content": "Lymphadenopathy"}, {"node": "E.5", "content": "Rashes"}, {"node": "E.6", "content": "Genital and anal lesions or discharge"}, {"node": "E.7", "content": "Neurologic examination"}]}, {"node": "F", "content": "Laboratory studies", "children": [{"node": "F.1", "content": "CD4 count, HIV viral load"}, {"node": "F.2", "content": "HIV genotype assay for drug resistance"}, {"node": "F.3", "content": "CBC and differential"}, {"node": "F.4", "content": "Liver function tests, creatinine, electrolytes, fasting glucose"}, {"node": "F.5", "content": "Syphilis test"}, {"node": "F.6", "content": "Serology for hepatitis A, B, C, Toxoplasma gondii, varicella, CMV"}, {"node": "F.7", "content": "G6PD assay"}, {"node": "F.8", "content": "PPD"}, {"node": "F.9", "content": "Pap smear"}]}, {"node": "G", "content": "Integrate history, physical examination, and laboratory tests to determine", "children": [{"node": "G.1", "content": "Strength of immune system"}, {"node": "G.2", "content": "Possible presence of active opportunistic infections"}, {"node": "G.3", "content": "Need for active treatment against opportunistic infections, prophylaxis, and/or antiretroviral therapy"}]}, {"node": "J", "content": "Prophylaxis for opportunistic infections", "children": [{"node": "J.1", "content": "Contingent upon CD4 count and prior infections"}, {"node": "J.2", "content": "See Table 3 for details"}]}, {"node": "K", "content": "Immunizations", "children": [{"node": "K.1", "content": "Pneumococcal vaccine (often deferred until CD4 count >200 cells/mm\u00b3)"}, {"node": "K.2", "content": "Hepatitis A (for patients who practice anal intercourse or international travelers) contingent upon CD4 count and prior infections"}, {"node": "K.3", "content": "Hepatitis B"}, {"node": "K.4", "content": "Tetanus, diphtheria, and acellular pertussis boosters"}, {"node": "K.5", "content": "Influenza (yearly)"}]}, {"node": "H", "content": "Antiretroviral treatment", "children": [{"node": "H.1", "content": "Decision to treat based on clinical status, history of opportunistic infections, CD4 counts, and viral load"}, {"node": "H.2", "content": "Treatment thresholds and recommended agents change frequently"}, {"node": "H.3", "content": "Refer patient to an HIV specialist or refer to www.aidsinfo.nih.gov for the latest recommendations"}]}, {"node": "H", "content": "Monitoring", "children": [{"node": "H.1", "content": "Repeat CD4 count and viral load 2\u20138 wk following treatment initiation"}, {"node": "H.2", "content": "Repeat testing every 3\u20134 mo"}]}]}